BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1765105)

  • 1. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2].
    Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP
    Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
    Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
    Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
    Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monofunctional platinum amine complexes destabilize DNA significantly.
    Bauer C; Peleg-Shulman T; Gibson D; Wang AH
    Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-substituted diaqua(1,2-diphenylethylenediamine)platinum(II) sulfate reacts with DNA through a dissociable complex.
    Bernges F; Holler E
    Eur J Biochem; 1992 Sep; 208(3):573-9. PubMed ID: 1396663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipophilicity of amylamine and amylglycine ligands on biological activity of new anticancer cisplatin analog.
    Safa Shams Abyaneh F; Eslami Moghadam M; Hossaini Sadr M; Divsalar A
    J Biomol Struct Dyn; 2018 Mar; 36(4):893-905. PubMed ID: 28335682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
    Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
    Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
    Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
    Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
    Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
    Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Condensation Reactions Involving Pt(II) /Pd(II) -OH2 , Pt-NH3 , and Cytosine-NH2 Groups: New Twists in Cisplatin-Nucleobase Chemistry.
    Yin-Bandur L; Sanz Miguel PJ; Rodríguez-Santiago L; Sodupe M; Berghaus M; Lippert B
    Chemistry; 2016 Sep; 22(38):13653-68. PubMed ID: 27516223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.